Meeting
2013 ASCO Annual Meeting
Molecular biomarkers as predictive factors of pCR for early triple-negative breast cancer.
Authors
Ismael Ghanem
Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain
Ismael Ghanem , Carlos Castañeda , Ana Perez-Campos , Oscar Toldos , Blanca Sancho Perez , Luis Manso , Jose Luis Rodriguez-Peralto , Mónica Calderón , Hernan Cortes-Funes , David Lora , Rosa Garcia-Martin , Eva Ciruelos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Triple-Negative Breast Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1041)
DOI
10.1200/jco.2013.31.15_suppl.1041
Abstract #
1041
Poster Bd #
18H
Abstract Disclosures
Similar Posters
First Author: Neal A. Fischbach
Poster
2015 ASCO Annual Meeting
Protein activation mapping and exploratory predictive markers for pCR in triple-negative breast cancer patients treated with neratinib in the I-SPY 2 TRIAL.
First Author: Julia Dianne Wulfkuhle
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel.
First Author: Noa Ben-Baruch
Poster
2014 ASCO Annual Meeting
Transcriptional expression of Bcl-2 as predictive of response to neoadjuvant chemotherapy with trastuzumab in HER2-positive ER-positive breast cancer patients.
First Author: Maki Tanioka